Gueorguieva I - Search Results

1

Models for change in tumour size, appearance of new lesions and survival probability in patients with advanced epithelial ovarian cancer.

Zecchin C, Gueorguieva I, Enas NH, Friberg LE. Zecchin C, et al. Among authors: gueorguieva i. Br J Clin Pharmacol. 2016 Sep;82(3):717-27. doi: 10.1111/bcp.12994. Epub 2016 Jun 8. Br J Clin Pharmacol. 2016. PMID: 27136318 Free PMC article. Clinical Trial.

2

Early change in tumour size predicts overall survival in patients with first-line metastatic breast cancer.

Tate SC, Andre V, Enas N, Ribba B, Gueorguieva I. Tate SC, et al. Among authors: gueorguieva i. Eur J Cancer. 2016 Oct;66:95-103. doi: 10.1016/j.ejca.2016.07.009. Epub 2016 Aug 18. Eur J Cancer. 2016. PMID: 27544929

3

A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis.

Ribba B, Holford NH, Magni P, Trocóniz I, Gueorguieva I, Girard P, Sarr C, Elishmereni M, Kloft C, Friberg LE. Ribba B, et al. Among authors: gueorguieva i. CPT Pharmacometrics Syst Pharmacol. 2014 May 7;3(5):e113. doi: 10.1038/psp.2014.12. CPT Pharmacometrics Syst Pharmacol. 2014. PMID: 24806032 Free PMC article.

4

Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer.

Gueorguieva I, Tabernero J, Melisi D, Macarulla T, Merz V, Waterhouse TH, Miles C, Lahn MM, Cleverly A, Benhadji KA. Gueorguieva I, et al. Cancer Chemother Pharmacol. 2019 Nov;84(5):1003-1015. doi: 10.1007/s00280-019-03931-1. Epub 2019 Sep 3. Cancer Chemother Pharmacol. 2019. PMID: 31482224

5

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer.

Melisi D, Garcia-Carbonero R, Macarulla T, Pezet D, Deplanque G, Fuchs M, Trojan J, Oettle H, Kozloff M, Cleverly A, Smith C, Estrem ST, Gueorguieva I, Lahn MMF, Blunt A, Benhadji KA, Tabernero J. Melisi D, et al. Among authors: gueorguieva i. Br J Cancer. 2018 Nov;119(10):1208-1214. doi: 10.1038/s41416-018-0246-z. Epub 2018 Oct 15. Br J Cancer. 2018. PMID: 30318515 Free PMC article. Clinical Trial.

6

Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials.

Gueorguieva I, Jackson K, Wrighton SA, Sinha VP, Chien JY. Gueorguieva I, et al. Br J Clin Pharmacol. 2010 Oct;70(4):523-36. doi: 10.1111/j.1365-2125.2010.03731.x. Br J Clin Pharmacol. 2010. PMID: 20840444 Free PMC article.

7

Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose.

Cheung SYA, Rodgers T, Aarons L, Gueorguieva I, Dickinson GL, Murby S, Brown C, Collins B, Rowland M. Cheung SYA, et al. Among authors: gueorguieva i. Br J Pharmacol. 2018 Jan;175(1):67-83. doi: 10.1111/bph.14071. Epub 2017 Dec 1. Br J Pharmacol. 2018. PMID: 29053169 Free PMC article.

8

Investigating the impact of target lesion selection on drug effect evaluation and tumour growth rate determination using tumour growth inhibition models: Example of malignant pleural mesothelioma patients treated with cisplatin alone or in combination with pemetrexed.

Lombard A, Mistry H, Chapman SC, Gueorguieva I, Aarons L, Ogungbenro K. Lombard A, et al. Among authors: gueorguieva i. Eur J Pharm Sci. 2021 Jun 1;161:105781. doi: 10.1016/j.ejps.2021.105781. Epub 2021 Mar 2. Eur J Pharm Sci. 2021. PMID: 33667665 Clinical Trial.

9

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM.

Langdon G, Gueorguieva I, Aarons L, Karlsson M. Langdon G, et al. Among authors: gueorguieva i. Eur J Clin Pharmacol. 2007 May;63(5):485-98. doi: 10.1007/s00228-007-0264-x. Epub 2007 Mar 8. Eur J Clin Pharmacol. 2007. PMID: 17345074 Clinical Trial.

10

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA).

Hecht JR, Lonardi S, Bendell J, Sim HW, Macarulla T, Lopez CD, Van Cutsem E, Muñoz Martin AJ, Park JO, Greil R, Wang H, Hozak RR, Gueorguieva I, Lin Y, Rao S, Ryoo BY. Hecht JR, et al. Among authors: gueorguieva i. J Clin Oncol. 2021 Apr 1;39(10):1108-1118. doi: 10.1200/JCO.20.02232. Epub 2021 Feb 8. J Clin Oncol. 2021. PMID: 33555926 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page